GIULIANI, Daniela
 Distribuzione geografica
Continente #
NA - Nord America 14.087
AS - Asia 5.287
EU - Europa 4.560
SA - Sud America 714
AF - Africa 74
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 8
Totale 24.742
Nazione #
US - Stati Uniti d'America 13.951
CN - Cina 1.866
GB - Regno Unito 1.848
SG - Singapore 1.645
HK - Hong Kong 724
IT - Italia 613
BR - Brasile 597
SE - Svezia 506
DE - Germania 381
UA - Ucraina 283
RU - Federazione Russa 262
TR - Turchia 258
VN - Vietnam 257
FI - Finlandia 196
KR - Corea 172
FR - Francia 133
BG - Bulgaria 100
CA - Canada 72
IN - India 70
JP - Giappone 52
AR - Argentina 49
ID - Indonesia 49
ES - Italia 45
MX - Messico 35
ZA - Sudafrica 35
BD - Bangladesh 31
IE - Irlanda 31
NL - Olanda 31
BE - Belgio 30
PL - Polonia 26
IQ - Iraq 25
LT - Lituania 20
PK - Pakistan 19
EC - Ecuador 18
CL - Cile 15
IR - Iran 15
AU - Australia 11
SA - Arabia Saudita 11
MY - Malesia 10
PH - Filippine 10
VE - Venezuela 10
EG - Egitto 9
TW - Taiwan 9
AE - Emirati Arabi Uniti 8
AT - Austria 8
CU - Cuba 8
JO - Giordania 8
PY - Paraguay 8
CZ - Repubblica Ceca 7
CO - Colombia 6
EU - Europa 6
KE - Kenya 6
LB - Libano 6
MA - Marocco 6
PE - Perù 6
RO - Romania 6
AM - Armenia 5
HU - Ungheria 5
JM - Giamaica 5
KZ - Kazakistan 5
TN - Tunisia 5
UZ - Uzbekistan 5
AZ - Azerbaigian 4
CH - Svizzera 4
CI - Costa d'Avorio 4
DO - Repubblica Dominicana 4
IL - Israele 4
LK - Sri Lanka 4
AL - Albania 3
DZ - Algeria 3
GR - Grecia 3
HN - Honduras 3
LU - Lussemburgo 3
NO - Norvegia 3
UY - Uruguay 3
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
CR - Costa Rica 2
DK - Danimarca 2
EE - Estonia 2
GT - Guatemala 2
KG - Kirghizistan 2
LV - Lettonia 2
LY - Libia 2
OM - Oman 2
RS - Serbia 2
SY - Repubblica araba siriana 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BO - Bolivia 1
BW - Botswana 1
BZ - Belize 1
CG - Congo 1
ET - Etiopia 1
GD - Grenada 1
GE - Georgia 1
GY - Guiana 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
MD - Moldavia 1
Totale 24.731
Città #
Fairfield 1.500
Santa Clara 1.327
Southend 1.276
Ashburn 1.241
Singapore 895
Woodbridge 860
Houston 808
Chandler 795
Hefei 720
Hong Kong 718
Jacksonville 605
Seattle 563
Ann Arbor 526
Cambridge 502
Wilmington 478
Dearborn 415
Nyköping 325
Chicago 319
Beijing 277
London 273
Los Angeles 266
Seoul 169
Modena 166
Izmir 138
New York 126
The Dalles 124
San Diego 121
Salt Lake City 115
Princeton 108
Eugene 100
Sofia 99
Ho Chi Minh City 97
Des Moines 85
Helsinki 84
Council Bluffs 82
Shanghai 82
Buffalo 72
Elk Grove Village 70
Dallas 67
Moscow 64
São Paulo 63
Columbus 56
Redwood City 55
Hanoi 54
Tampa 50
Munich 48
Milan 42
Tokyo 39
Bologna 37
Bremen 35
Jakarta 34
Falls Church 32
Kent 32
Sterling 32
Dublin 31
Lancaster 31
Atlanta 29
Brussels 29
Norwalk 27
Boardman 25
Frankfurt am Main 25
Guangzhou 25
Phoenix 24
Montreal 23
Poplar 22
Brooklyn 21
Denver 21
Reggio Emilia 21
Toronto 21
Johannesburg 20
Miami 20
Chennai 19
Detroit 19
Warsaw 19
Ankara 18
Kunming 18
Stockholm 18
Dulles 17
Redondo Beach 17
Rio de Janeiro 17
Rome 17
Turin 17
Turku 17
Xi'an 17
Fremont 16
Kilburn 16
Orem 15
Hounslow 14
Pittsburgh 14
Baghdad 13
Belo Horizonte 13
Haiphong 13
Manchester 12
Parma 12
San Francisco 12
Biên Hòa 11
Boston 11
Las Vegas 11
Ottawa 11
San Jose 11
Totale 18.117
Nome #
Activation of an efferent cholinergic pathway produces strong protection against myocardial ischemia/reperfusion injury in rats 420
NDP-α-MSH induces intense neurogenesis and cognitive recovery in Alzheimer transgenic mice through activation of melanocortin MC4 receptors 407
Effects of ketamine anesthesia on central nociceptive processing in the rat: a 2-deoxyglucose study. 397
Mechanisms of Hydrogen Sulfide against the Progression of Severe Alzheimer’s Disease in Transgenic Mice at Different Ages 393
Both early and delayed treatment with melanocortin 4 receptor-stimulating melanocortins produces neuroprotection in cerebral ischemia 386
Vagus nerve mediates the protective effects of melanocortins against cerebral and systemic damage after ischemic stroke. 376
Effect of sumatriptan in different models of pain in rats 355
Functional recovery after delayed treatment of ischemic stroke with melanocortins is associated with overexpression of the activity-dependent gene Zif268 353
Melanocortins counteract inflammatory and apoptotic responses to prolonged myocardial ischemia/reperfusion through a vagus nerve-mediated mechanism 351
Effect of late treatment with gamma-hydroxybutyrate on the histological and behavioral consequences of transient brain ischemia in the rat. 338
Regenerative potential of human dental pulp stem cells in the treatment of stress urinary incontinence: In vitro and in vivo study 323
Effects of COX1-2/5-LOX blockade in Alzheimer transgenic 3xTg-AD mice 318
Independent time courses of supraspinal nociceptive activity and spinally mediated behavior during tonic pain 299
NDP-α-MSH attenuates heart and liver responses to myocardial reperfusion via the vagus nerve and JAK/ERK/STAT signaling 299
A COMPARATIVE-STUDY OF B-HT 920 AND DIAZEPAM IN THE X-MAZE FEEDING TEST 296
BEHAVIOURAL EFFECTS OF THE DOPAMINE D3 RECEPTOR AGONIST, 7-OH-DPAT IN RATS. 287
Up-regulation of the canonical Wnt-3A and Sonic hedgehog signaling underlies melanocortin-induced neurogenesis after cerebral ischemia 282
CNS pattern of metabolic activity during tonic pain: evidence for modulation by beta-endorphin 281
BEHAVIOURAL EFFECTS INDUCED IN RATS AND CHICKS BY D2 DOPAMINE AGONISTS 281
Cannabimimetic activity in rats and pigeons of HU 210, a potent antiemetic drug 280
Melanocortins protect against multiple organ dysfunction syndrome in mice 277
Activation of the cholinergic anti-inflammatory pathway reduces NF-kappa B activation, blunts TNF-alpha production, and protects against splanchnic artery occlusion shock 273
Effects of aglycone genistein in a rat experimental model of postmenopausal metabolic syndrome. 271
B-HT 920-INDUCED EFFECTS ON RAT FEEDING BEHAVIOUR 271
Multiple beneficial effects of melanocortin MC4 receptor agonists in experimental neurodegenerative disorders: Therapeutic perspectives 270
THE D2 AGONIST B-HT 920 POTENTLY ANTAGONIZES RAT GROOMING. 260
Melanocortins and the cholinergic anti-inflammatory pathway. 259
Modulation of the JAK/ERK/STAT signaling in melanocortin-induced inhibition of local and systemic responses to myocardial ischemia/reperfusion 254
Melanocortin Receptor-4 Gene Polymorphisms in Glioblastoma Patients Treated with Concomitant Radio-Chemotherapy. 253
Centrally acting leptin induces a resuscitating effect in haemorrhagic shock in rats. 252
Neuroleptic-like profile of the cannabinoid agonist, HU 210, on rodent behavioural models 249
Melanocortin MC(4) receptor agonists counteract late inflammatory and apoptotic responses and improve neuronal functionality after cerebral ischemia. 249
BEHAVIOURAL ASSESSMENT IN RATS OF THE ANTIPSYCHOTIC POTENTIAL OF THE POTENT DOPAMINE D2 RECEPTOR ANTAGONIST, (-) ETICLOPRIDE 248
Influence of sildenafil on copulatory behaviour in sluggish or normal ejaculator male rats: a central dopamine mediated effect? 247
Modulatory activity of sildenafil on copulatory behaviour of both intact and castrated male rats 247
Adrenocorticotropin reverses hemorrhagic shock in anesthetized rats through the rapid activation of a vagal anti-inflammatory pathway 246
Melanocortin 4 receptor activation protects against testicular ischemia-reperfusion injury by triggering the cholinergic antiinflammatory pathway. 244
Sexual attraction and copulation in male rats: effects of the dopamine agonist SND 919 242
A COMPARATIVE BEHAVIOURAL ANALYSIS IN RATS OF THE D2 AGONIST RU 24213 AND TWO NEW STRUCTURALLY SIMILAR COMPOUNDS 241
Melanocortin 4 receptor stimulation decreases pancreatitis severity in rats by activation of the cholinergic anti-inflammatory pathway 241
INFLUENCE OF ACTH-(1-24) ON INGESTIVE BEHAVIOURS 239
Behavioral effects induced by the dopamine D-3 agonist 7-OH-DPAT in sexually-active and -inactive male rats 235
Further evidence that melanocortins prevent myocardial reperfusion injury by activating melanocortin MC3 receptors 233
Selective melanocortin MC4 receptor agonists reverse haemorrhagic shock and prevent multiple organ damage 233
Melanocortins protect against brain damage and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer׳s disease. 233
Efferent vagal fibre stimulation blunts nuclear factor-kappa B activation and protects against hypovolemic hemorrhagic shock 231
Effects of )eticlopride and 7-OH-DPAT on the tail-suspension test in mice 230
EFFECT OF THE D2-AUTORECEPTOR AGONIST B-HT-958 ON BOTH SPONTANEOUS AND ACTH-INDUCED STRETCHING, YAWNING AND GROOMING IN THE RAT 228
Neuroprotection in focal cerebral ischemia owing to delayed treatment with melanocortins. 228
Melanocortins promote neurogenesis and counteract cognitive decline in a transgenic mouse model of moderate Alzheimer’s disease 227
Molecular Changes Induced in Rat Liver by Hemorrhage and Effects of Melanocortin Treatment. 226
Differential behavioral response to dopamine D-2 agonists by sexually naive, sexually active, and sexually inactive male rats 225
Azione neuroprotettiva dei peptici melanocortinici nell’ictus ischemico sperimentale 223
Melanocortins protect against progression of Alzheimer's disease in triple-transgenic mice by targeting multiple pathophysiological pathways 223
B-HT 920 STIMULATES FEEDING AND ANTAGONIZES ANOREXIA INDUCED BY ACTH AND IMMOBILIZATION 223
THE CANNABINOID AGONIST HU 210 MODIFIES RAT BEHAVIOURAL RESPONSES TO NOVELTY AND STRESS 222
The disaccharide trehalose inhibits proinflammatory phenotype activation in macrophages and prevents mortality in experimental septic shock 221
EFFECTS OF THE CANNABINOID RECEPTOR AGONIST, HU 210, ON INGESTIVE BEHAVIOUR AND BODY WEIGHT OF RATS 221
THE SELECTIVE D-2-DOPAMINE-RECEPTOR ANTAGONIST ETICLOPRIDE COUNTERACTS THE EJACULATIO-PRAECOX INDUCED BY THE SELECTIVE D-2-DOPAMINE AGONIST SND-919 IN THE RAT 219
Involvement of dopamine receptors in the antipsychotic profile of )eticlopride 219
BRAIN ACETYLCHOLINE IS INVOLVED IN THE ACTH-INDUCED BEHAVIORAL SYNDROME IN RATS 218
Treatment of cerebral ischemia with melanocortins acting at MC(4) receptors induces marked neurogenesis and long-lasting functional recovery. 218
BEHAVIOURAL PROFILE IN CHICKEN OF CQ 32-084 AND CQP 201-403, TWO DOPAMINE AGONISTS 216
Broad therapeutic treatment window of [Nle(4), D-Phe(7)]alpha-melanocyte-stimulating hormone for long-lasting protection against ischemic stroke, in Mongolian gerbils 213
MC3 receptors are involved in the protective effect of melanocortins in myocardial ischemia/reperfusion-induced arrhythmias 212
Rat cognitive function during and after treatment with the cannabinoid agonist, HU 210 209
HU 210: A potent tool for investigations of the cannabinoid system 206
Melanocortins as potential therapeutic agents in severe hypoxic conditions. 206
Protective effects of melanocortins on short-term changes in a rat model of traumatic brain injury 205
SUPPRESSIVE EFFECT OF THE DOPAMINE D2-RECEPTOR AGONIST B-HT 920 ON RAT GROOMING 203
Recombinant human erythropoietin improves angiogenesis and wound healing in experimental burn wounds 203
Melanocortin receptor agonist NDP-α-MSH improves cognitive deficits and microgliosis but not amyloidosis in advanced stages of AD progression in 5XFAD and 3xTg mice 202
Inhibitory effects of the cannabinoid agonist HU 210 on rat sexual behaviour 198
Influence of the cannabinoid agonist HU 210 on cocaine- and CQP 201-403-induced behavioural effects in rat 198
Hydrogen sulfide slows down progression of experimental Alzheimer's disease by targeting multiple pathophysiological mechanisms 198
I neuropeptidi melanocortinici nell’approccio cardioprotettivo contro il danno da ischemia e da riperfusione 197
INVOLVEMENT OF DOPAMINE D2 RECEPTORS IN THE EFFECT OF COCAINE ON SEXUAL BEHAVIOUR AND STRETCHING-YAWNING OF MALE RATS. 197
Oxidative stress in Alzheimer's disease: In vitro therapeutic effect of amniotic fluid stem cells extracellular vesicles 196
PCSK9 ablation attenuates Aβ pathology, neuroinflammation and cognitive dysfunctions in 5XFAD mice 195
NPY-induced inhibition of male copulatory acivity is a direct behavioural effect 194
Bioresorbable Nanostructured Chemical Sensor for Monitoring of pH Level In Vivo 194
GROOMING AND STRETCHING-YAWNING - 2 BEHAVIORAL POINTERS OF D2 DOPAMINE RECEPTOR AGONISTIC EFFECT 191
Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task 188
Melanocortins protect against myocardial ischemia/reperfusion injury through the activation of an efferent cholinergic pathway 186
INABILITY OF )DEPRENYL TO MODIFY COPULATORY PERFORMANCE IN THE MALE-RAT, WHETHER OR NOT STIMULATED BY THE SELECTIVE D-2 DOPAMINE AGONIST SND-919 183
Synthesis, resolution, and preliminary evaluation of trans-2-amino-6(5)-hydroxy-1-phenyl-2,3-dihydro-1H-indenes and related derivatives as dopamine receptors ligands 183
Sull'identificazione di una via colinergica anti-shock fisiologica e dipendente dalle melanocortine. 183
HYPERPHAGIC EFFECT OF B-HT-920 IN A MODIFIED X-MAZE TEST 177
Melanocortin receptor-4 and glioblastoma cells: effects of the selective antagonist ML00253764 alone and in combination with temozolomide on cell proliferation and apoptosis. 176
Involvement of the brain histaminergic system in the melanocortin MC4 receptor agonist RO27-3225-induced resuscitating effect in haemorrhage-shocked rats – haemodynamic studies. 169
INVOLVEMENT OF THE HISTAMINERGIC SYSTEM IN CENTRALLY-ACTING LEPTIN-EVOKED RESUSCITATING EFFECT IN HAEMORRHAGIC SHOCK IN RATS 167
Influence of eticlopride on cocaine- and DA D-2 agonist-induced behavioral effects in rats 163
Influence of sildenafil on central dopamine-mediated behaviour in male rats 162
BEHAVIORAL EVIDENCE THAT DIFFERENT NEUROCHEMICAL MECHANISMS UNDERLY STRETCHING-YAWNING AND PENILE ERECTION INDUCED IN MALE-RATS BY SND-919, A NEW SELECTIVE D-2 DOPAMINE-RECEPTOR AGONIST 161
Protective effects of the melanocortin analog NDP-α-MSH in rats undergoing cardiac arrest 156
EFFECTS OF THE DOPAMINE D(2)-AGONISTS LISURIDE AND CQ 32-084 ON RAT-FEEDING BEHAVIOR 155
Involvement of the histaminergic system in the resuscitating effect of centrally acting leptin in haemorrhagic shock in rats 155
Effect of the cannabinoid receptor agonist, HU 210, on body weight and feeding behaviour of rats 153
EFFECT ON RAT-FEEDING BEHAVIOR OF 2 SELECTIVE D-2-DOPAMINE AGONISTS 149
PCSK9 Affects Astrocyte Cholesterol Metabolism and Reduces Neuron Cholesterol Supplying In Vitro: Potential Implications in Alzheimer’s Disease 146
Totale 23.836
Categoria #
all - tutte 101.856
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 101.856


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.314 0 0 0 0 0 119 190 303 89 329 162 122
2021/20222.117 38 297 267 103 36 71 152 91 196 126 501 239
2022/20232.075 239 237 155 215 198 365 25 189 265 14 71 102
2023/20241.252 43 89 86 108 253 109 115 191 35 28 85 110
2024/20255.045 186 44 65 333 955 771 340 300 528 296 613 614
2025/20265.322 675 454 722 1.262 1.949 260 0 0 0 0 0 0
Totale 24.934